IP Library Granted Patent US 10,751,645
Granted Patent B2
US 10,751,645 · App. 15/882,998 · Granted Aug 25, 2020

Chromatography ligand

Inventors: Carina Engstrand (Uppsala, SE); Annika Forss (Uppsala, SE); Gunnar Glad (Uppsala, SE); Bo-Lennart Johansson (Uppsala, SE); Hans J Johansson (Uppsala, SE); Jean-Luc Maloisel (Uppsala, SE)
Assignee: GE Healthcare BioProcess R&D AB
B01D15/3828B01D15/327B01D15/363B01D15/3804B01D15/3809B01D15/3847B01J20/286B01J20/3253B01J20/3285B01J41/20C07K1/165C07K1/36C07K16/00C07K16/065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,751,645
App. No.
15/882,998
Granted
Aug 25, 2020
Kind
B2
Abstract

The present invention relates to a chromatography ligand defined by the following formula R 1 —R 2 —N(R 3 )—R 4 —R 5 wherein R 1 is a substituted or non-substituted phenyl group; R 2 is a hydrocarbon chain comprising 0-4 carbon atoms; R 3 is a hydrocarbon chain comprising 1-3 carbon atoms; R 4 is a hydrocarbon chain comprising 1-5 carbon atoms; and R 5 is OH or H. The invention also comprises a separation matrix, comprising the described ligands coupled to a porous support, such as particles or a membrane. The ligand and matrix according to the invention is useful for purification of biomolecules or organic compounds, such as proteins, polypeptides, DNA etc. An advantageous use according to the invention is the purification of antibodies.

Claims (34)

1. A separation matrix comprising a chromatography ligand coupled to a support wherein the ligand is defined by the following formula:

R 1 —R 2 —N(R 3 )—R 4 —R 5

wherein

R 1 is a non-substituted phenyl group;

R 2 is methylene;

R 3 is a straight saturated hydrocarbon chain comprising 1-3 carbon atoms;

R 4 is a straight saturated hydrocarbon chain comprising 1-5 carbon atoms; and

R 5 is OH or H,

wherein said chromatography ligand is coupled to a support via the tertiary amine nitrogen atom through a linker such that the tertiary amine of the ligand is converted to a quaternary amine.

2. The matrix of claim 1 , wherein R 4 is CH 2 —CH 2 .

3. The matrix of claim 1 , wherein R 3 is —CH 3 .

4. The matrix of claim 1 , wherein R 4 is —CH 2 —CH 2 —CH 2 —.

5. The matrix of claim 1 , wherein the ligand comprises N-benzyl-N-methyl ethanol amine.

6. The matrix of claim 1 , wherein the ligand comprises N,N-dimethyl benzyl amine.

7. The matrix of claim 1 , wherein the support is porous agarose.

8. The matrix of claim 1 , wherein the support comprises substantially spherical particles.

9. The matrix of claim 1 , wherein the matrix is packed in a chromatography column.

10. The matrix of claim 1 , wherein the support comprises a membranous structure.

11. A separation matrix comprising a chromatography ligand coupled to a support wherein the ligand is defined by the following formula:

R 1 —R 2 —N(R 3 )—R 4 —H

wherein

R 1 is a non-substituted phenyl group;

R 2 is a methylene;

R 3 is a straight saturated hydrocarbon chain comprising 1-3 carbon atoms; and

R 4 is a straight saturated hydrocarbon chain comprising 1-5 carbon atoms,

wherein said chromatography ligand is coupled to a support via the tertiary amine nitrogen atom through a linker such that the tertiary amine of the ligand is converted to a quaternary amine.

12. The matrix of claim 11 , wherein R 4 is —CH 2 —CH 2 —.

13. The matrix of claim 11 , wherein R 3 is —CH 3 .

14. The matrix of claim 11 , wherein R 4 is —CH 2 —CH 2 —CH 2 —.

15. The matrix of claim 11 , wherein the ligand comprises N,N-dimethyl benzyl amine.

16. The matrix of claim 11 , wherein the support is porous agarose.

17. The matrix of claim 11 , wherein the support comprises substantially spherical particles.

18. The matrix of claim 11 , wherein the matrix is packed in a chromatography column.

19. The matrix of claim 11 , wherein the support comprises a filter.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: ENGSTRAND, CARINA; FORSS, ANNIKA; GLAD, GUNNAR; JOHANSSON, BO-LENNART; MALOISEL, JEAN-LUC
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 044782/0485 →
Priority Claims (2)
SE 0402558 · Oct 21, 2004 · national
SE 0402910 · Nov 26, 2004 · national
Continuity (4)
Division 14542816 · Nov 17, 2014
Continuation 12984132 · Jan 4, 2011
Continuation 11577208
Related Publication 20180154281A1 · Jun 7, 2018